The DNA repair protein ATM as a target in autism spectrum disorder

Impairment of the GABAergic system has been reported in epilepsy, autism, attention deficit hyperactivity disorder, and schizophrenia. We recently demonstrated that ataxia telangiectasia mutated (ATM) directly shapes the development of the GABAergic system. Here, we show for the first time to our knowledge how the abnormal expression of ATM affects the pathological condition of autism. We exploited 2 different animal models of autism, the methyl CpG binding protein 2–null (Mecp2y/–) mouse model of Rett syndrome and mice prenatally exposed to valproic acid, and found increased ATM levels. Accordingly, treatment with the specific ATM kinase inhibitor KU55933 (KU) normalized molecular, functional, and behavioral defects in these mouse models, such as (a) delayed GABAergic development, (b) hippocampal hyperexcitability, (c) low cognitive performances, and (d) social impairments. Mechanistically, we demonstrate that KU administration to WT hippocampal neurons leads to (a) higher early growth response 4 activity on Kcc2b promoter, (b) increased expression of Mecp2, and (c) potentiated GABA transmission. These results provide evidence and molecular substrates for the pharmacological development of ATM inhibition in autism spectrum disorders.

[1]  Chiara Nicolini,et al.  The valproic acid-induced rodent model of autism , 2018, Experimental Neurology.

[2]  M. Woodin,et al.  Restoring GABAergic inhibition rescues memory deficits in a Huntington’s disease mouse model , 2018, Proceedings of the National Academy of Sciences.

[3]  I. Barajon,et al.  Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring , 2017, Biological Psychiatry.

[4]  Jennifer L. Levy,et al.  Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS. , 2017, Cell reports.

[5]  M. Passafaro,et al.  Pharmacological Modulation of AMPAR Rescues Intellectual Disability-Like Phenotype in Tm4sf2−/y Mice , 2017, Cerebral cortex.

[6]  W. Lasoń,et al.  The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D. , 2017, The international journal of biochemistry & cell biology.

[7]  C. Garlanda,et al.  Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects , 2017, eLife.

[8]  A. Bird,et al.  The Role of Epigenetic Mechanisms in the Regulation of Gene Expression in the Nervous System , 2016, The Journal of Neuroscience.

[9]  M. Sur,et al.  Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome , 2016, Proceedings of the National Academy of Sciences.

[10]  N. Landsberger,et al.  Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms. , 2016, Cerebral cortex.

[11]  M. Passafaro,et al.  New Role of ATM in Controlling GABAergic Tone During Development. , 2016, Cerebral cortex.

[12]  F. Antonucci,et al.  The Timing of the Excitatory-to-Inhibitory GABA Switch Is Regulated by the Oxytocin Receptor via KCC2 , 2016, Cell reports.

[13]  Wei Li,et al.  Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors , 2016, Proceedings of the National Academy of Sciences.

[14]  F. Gage,et al.  KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome , 2016, Proceedings of the National Academy of Sciences.

[15]  B. Burrell,et al.  Differential effects of GABA in modulating nociceptive vs. non-nociceptive synapses , 2015, Neuroscience.

[16]  Andreas R. Pfenning,et al.  Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes , 2015, Cell.

[17]  R. J. Mather,et al.  Selective Inhibition of KCC2 Leads to Hyperexcitability and Epileptiform Discharges in Hippocampal Slices and In Vivo , 2015, The Journal of Neuroscience.

[18]  A. Contestabile,et al.  Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome , 2015, Nature Medicine.

[19]  R. Corvò,et al.  Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019 , 2015, International journal of cancer.

[20]  N. Brandon,et al.  KCC2 activity is critical in limiting the onset and severity of status epilepticus , 2015, Proceedings of the National Academy of Sciences.

[21]  S. Hormuzdi,et al.  Neuronal chloride transport tuning , 2015, The Lancet.

[22]  Wei Li,et al.  Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice , 2015, Hippocampus.

[23]  H. Vinters,et al.  Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease , 2014, Science Translational Medicine.

[24]  X. Tian,et al.  The suppression of epileptiform discharges in cultured hippocampal neurons is regulated via alterations in full‐length tropomyosin‐related kinase type B receptors signalling activity , 2014, The European journal of neuroscience.

[25]  M. Mottolese,et al.  ATM kinase sustains HER2 tumorigenicity in breast cancer , 2014, Nature Communications.

[26]  P. Awadalla,et al.  Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy , 2014, EMBO reports.

[27]  I. Scheffer,et al.  A variant of KCC2 from patients with febrile seizures impairs neuronal Cl− extrusion and dendritic spine formation , 2014, EMBO reports.

[28]  J. Schuurs-Hoeijmakers,et al.  TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function , 2014, Nature Genetics.

[29]  M. Milanese,et al.  Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome , 2014, Neurobiology of Disease.

[30]  Y. Lee,et al.  Genome-wide pathway analysis in attention-deficit/hyperactivity disorder , 2014, Neurological Sciences.

[31]  Amene Shahrokhi,et al.  Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring , 2014, Science.

[32]  D. Reutens,et al.  Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice , 2013, Behavioural Brain Research.

[33]  S. Gau,et al.  Runs of Homozygosity Associated with Speech Delay in Autism in a Taiwanese Han Population: Evidence for the Recessive Model , 2013, PloS one.

[34]  S. Duarte,et al.  Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett Syndrome , 2013, PloS one.

[35]  N. Curtin,et al.  Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer , 2013, Molecular Cancer Therapeutics.

[36]  Tuoen Liu,et al.  Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. , 2012, Pharmacology & therapeutics.

[37]  J. Sarkaria,et al.  ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells , 2012, Journal of Neuro-Oncology.

[38]  Martin K. Schwarz,et al.  Evoked Axonal Oxytocin Release in the Central Amygdala Attenuates Fear Response , 2012, Neuron.

[39]  A. Alpár,et al.  Cracking Down on Inhibition: Selective Removal of GABAergic Interneurons from Hippocampal Networks , 2012, The Journal of Neuroscience.

[40]  David A. Lewis,et al.  Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia , 2012, Trends in Neurosciences.

[41]  M. Jäättelä,et al.  Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy* , 2011, The Journal of Biological Chemistry.

[42]  Lief E. Fenno,et al.  Neocortical excitation/inhibition balance in information processing and social dysfunction , 2011, Nature.

[43]  M. Greenberg,et al.  Neuronal activity-regulated gene transcription in synapse development and cognitive function. , 2011, Cold Spring Harbor perspectives in biology.

[44]  T. Rubino,et al.  Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism , 2011, Biological Psychiatry.

[45]  C. Rivera,et al.  Early Growth Response 4 Mediates BDNF Induction of Potassium Chloride Cotransporter 2 Transcription , 2011, The Journal of Neuroscience.

[46]  M. Lavin,et al.  ATM Activation by Oxidative Stress , 2010, Science.

[47]  D. deCatanzaro,et al.  Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid , 2010, Neuroscience.

[48]  C. Lord,et al.  Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.

[49]  Da-Qing Yang,et al.  The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt , 2010, Molecular Cancer Therapeutics.

[50]  K. Herrup,et al.  Cytoplasmic ATM in Neurons Modulates Synaptic Function , 2009, Current Biology.

[51]  I. Takasaki,et al.  Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions , 2009, Neuroscience Research.

[52]  Philippe Séguéla,et al.  Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. , 2009, Cerebral cortex.

[53]  T. Hei,et al.  Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells. , 2009, Cancer research.

[54]  B. Price,et al.  Activation of the Kinase Activity of ATM by Retinoic Acid Is Required for CREB-dependent Differentiation of Neuroblastoma Cells* , 2007, Journal of Biological Chemistry.

[55]  C. Rivera,et al.  Upregulation of the Neuron-Specific K+/Cl− Cotransporter Expression by Transcription Factor Early Growth Response 4 , 2006, The Journal of Neuroscience.

[56]  T. Timmusk,et al.  Neuronal K+/Cl– co‐transporter (KCC2) transgenes lacking neurone restrictive silencer element recapitulate CNS neurone‐specific expression and developmental up‐regulation of endogenous KCC2 gene , 2005, Journal of neurochemistry.

[57]  Y. Ben-Ari,et al.  Early expression of KCC2 in rat hippocampal cultures augments expression of functional GABA synapses , 2005, The Journal of physiology.

[58]  A. Addington,et al.  GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss , 2005, Molecular Psychiatry.

[59]  Pat Levitt,et al.  Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders , 2004, Trends in Neurosciences.

[60]  N. Logothetis.  The Underpinnings of the BOLD Functional Magnetic Resonance Imaging Signal , 2003, The Journal of Neuroscience.

[61]  Y. Ben-Ari.  Excitatory actions of gaba during development: the nature of the nurture , 2002, Nature Reviews Neuroscience.

[62]  Arnold R. Kriegstein,et al.  Is there more to gaba than synaptic inhibition? , 2002, Nature Reviews Neuroscience.

[63]  A. Barzilai,et al.  Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. , 2001, Cancer research.

[64]  A. Kriegstein,et al.  An excitatory GABAergic plexus in developing neocortical layer 1. , 2000, Journal of neurophysiology.

[65]  F. Alt,et al.  Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Xavier Leinekugel,et al.  Ca2+ Oscillations Mediated by the Synergistic Excitatory Actions of GABAA and NMDA Receptors in the Neonatal Hippocampus , 1997, Neuron.

[68]  A. Kriegstein,et al.  Excitatory GABA Responses in Embryonic and Neonatal Cortical Slices Demonstrated by Gramicidin Perforated-Patch Recordings and Calcium Imaging , 1996, The Journal of Neuroscience.

[69]  P. Rodier,et al.  Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei , 1996, The Journal of comparative neurology.

[70]  S. Akbarian,et al.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.

[71]  S. Sombati,et al.  Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. , 1995, Journal of neurophysiology.

[72]  K. Kuriyama,et al.  GABAA receptor stimulation enhances NMDA-induced Ca2+ influx in mouse cerebral cortical neurons in primary culture. , 1994, Brain research. Molecular brain research.

[73]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[74]  Ryszard Przewłocki,et al.  Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism , 2005, Neuropsychopharmacology.

[75]  I Khalilov,et al.  GABA is the principal fast-acting excitatory transmitter in the neonatal brain. , 1999, Advances in neurology.

[76]  R. Darnell,et al.  ATM binds to beta-adaptin in cytoplasmic vesicles. , 1998, Proceedings of the National Academy of Sciences of the United States of America.